David Howe

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 1

Top Topics

Rheumatoid Arthritis Patients

Monoclonal Antibody

Dendritic Cells

Disease Activity

Top Venues

Science translational medicine

Heptares Therapeutics (United Kingdom)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Heptares Therapeutics (United Kingdom) Sep 7o 2018

United Kingdom

Senior Director :: Clinical Development

Publications

Jodi L Karnell, Marius Albulescu, Stacey Drabic, Liangwei Wang, Rachel Moate, Manuel Baca, Vaheh Oganesyan, Michele Gunsior, Thomas Thisted, Li Yan, Jing Li, Ximing Xiong, Steven C Eck, Melissa de Los Reyes, Isharat Yusuf, Katie Streicher, Ulf Müller-Ladner, David Howe, Rachel Ettinger, Ronald Herbst, Jörn Drappa
A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity. Science translational medicine 11 (489) (2020)